Department of Cardiology, Peruvian Society of Cardiology, Lima, Perú.
Faculty of Medicine, Peruvian University Cayetano Heredia, Lima, Perú.
Vasc Endovascular Surg. 2024 Oct;58(7):762-768. doi: 10.1177/15385744241255421. Epub 2024 May 17.
The treatment of patients with severe aortic stenosis (SAS) who concomitantly present with abdominal aortic aneurysm (AAA) is not defined. Aortic valve replacement surgery, performed alone, increases the risk of AAA rupture. Transcatheter aortic valve replacement (TAVR) and endovascular abdominal aortic aneurysm repair (EVAR) in the same intervention, especially in high-risk patients, is a safe alternative. We report a case of simultaneous endovascular treatment of SAS and AAA and a mini literature review of nineteen cases with similar characteristics. Case report and literature review. An electronic search of PubMed and Scopus was performed from inception to December 2023. Nineteen case reports of simultaneous transcatheter aortic valve repair and endovascular aneurysm repair for SAS and symptomatic AAA were identified published in the literature. We regard the simultaneous endovascular approach to both pathologies as a promising treatment alternative for selected patients with severe aortic stenosis and abdominal aortic aneurysm. We highlight the need to conduct randomized clinical trials in this patient population.
同时患有严重主动脉瓣狭窄（SAS）和腹主动脉瘤（AAA）的患者的治疗方法尚未确定。单独进行主动脉瓣置换手术会增加 AAA 破裂的风险。在同一介入治疗中同时进行经导管主动脉瓣置换术（TAVR）和腹主动脉瘤腔内修复术（EVAR），特别是在高危患者中，是一种安全的替代方法。我们报告了一例同时进行经导管主动脉瓣置换术和腹主动脉瘤腔内修复术治疗 SAS 和 AAA 的病例，并对 19 例具有相似特征的病例进行了文献复习。病例报告和文献复习。从文献检索开始到 2023 年 12 月，我们在 PubMed 和 Scopus 上进行了电子检索。我们在文献中发现了 19 例同时进行经导管主动脉瓣修复和腹主动脉瘤腔内修复治疗 SAS 和有症状的 AAA 的病例报告。我们认为，对于患有严重主动脉瓣狭窄和腹主动脉瘤的选定患者，同时进行腔内治疗这两种疾病是一种很有前途的治疗选择。我们强调需要在这一患者群体中开展随机临床试验。
